Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
About this item
Full title
Author / Creator
LYM-3002 Investigators , Robak, Tadeusz , Huang, Huiqiang , Jin, Jie , Zhu, Jun , Liu, Ting , Samoilova, Olga , Pylypenko, Halyna , Verhoef, Gregor , Siritanaratkul, Noppadol , Osmanov, Evgenii , Alexeeva, Julia , Pereira, Juliana , Drach, Johannes , Mayer, Jiri , Hong, Xiaonan , Okamoto, Rumiko , Pei, Lixia , Rooney, Brendan , van de Velde, Helgi and Cavalli, Franco
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The substitution of bortezomib for vincristine in R-CHOP resulted in higher rates of complete response and nearly a doubling in progression-free survival among patients with advanced mantle-cell lymphoma not eligible for stem-cell transplantation.
Mantle-cell lymphoma is an incurable, aggressive hematologic cancer with a poor prognosis (median s...
Alternative Titles
Full title
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Authors, Artists and Contributors
Author / Creator
Robak, Tadeusz
Huang, Huiqiang
Jin, Jie
Zhu, Jun
Liu, Ting
Samoilova, Olga
Pylypenko, Halyna
Verhoef, Gregor
Siritanaratkul, Noppadol
Osmanov, Evgenii
Alexeeva, Julia
Pereira, Juliana
Drach, Johannes
Mayer, Jiri
Hong, Xiaonan
Okamoto, Rumiko
Pei, Lixia
Rooney, Brendan
van de Velde, Helgi
Cavalli, Franco
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1660950200
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1660950200
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1412096
